XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population

Background The human X-ray repair cross-complementing protein 1 (XRCC1) gene encodes for one of the major repair factors involved in base excision repair (BER), which is reported to be associated with the risk of several cancers. A few studies have explored the association between risk of hepatocellular carcinoma (HCC) and single-nucleotide polymorphisms (SNPs) in different DNA repair genes, with contradictory results. The purpose of this study was to evaluate the association between XRCC1 Arg399Gln polymorphism and susceptibility to HCC. Methods A total of 89 HCC patients and 99 randomly selected healthy controls were enrolled. Genotyping of XRCC1 rs25487 was performed by high-resolution melting analysis and Sanger sequencing. Results On univariate analysis, a statistically significant association was found between risk of HCC and XRCC1 399Arg/Gln genotype (odd ratio [OR] = 1.88; 95% CI, 1.04-3.43), which was confirmed after adjusting by sex (OR = 1.94; 95% CI, 1.04-3.63). Although not significant, Kaplan-Meier analysis showed a decreased median survival in Arg/Gln genotype carriers in comparison with Arg/Arg carriers. Conclusions To our knowledge, this is the first study reporting an association between BER SNP and HCC risk in a population of central-southern Italy.

[1]  Dong Zhao,et al.  The association of six non‐synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta‐analysis , 2016, Journal of cellular and molecular medicine.

[2]  Z. Mo,et al.  X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer , 2015, The International journal of biological markers.

[3]  J. S. Wu,et al.  Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma. , 2014, Genetics and molecular research : GMR.

[4]  J. Ma,et al.  Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis. , 2014, Genetics and molecular research : GMR.

[5]  Yu Yin,et al.  XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis , 2014, Tumor Biology.

[6]  Jing-yi Shi,et al.  Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis. , 2014, Gene.

[7]  Haiyu Wang,et al.  An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[8]  Yun-peng Qi,et al.  XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis , 2014, Molecular Biology Reports.

[9]  Yoshiaki Yamamoto,et al.  ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy. , 2013, Molecular and clinical oncology.

[10]  Yong Gu,et al.  The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[11]  Wenyaw Chan,et al.  Statistical Methods in Medical Research , 2013, Model. Assist. Stat. Appl..

[12]  J. Li,et al.  Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis , 2013, Tumor Biology.

[13]  Hui Liu,et al.  X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. , 2012, World journal of gastroenterology.

[14]  Haijun Zhang,et al.  Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. , 2011, Anticancer research.

[15]  A. Baierl,et al.  No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. , 2011, Cancer Epidemiology.

[16]  A. Olshan,et al.  High XRCC1 Protein Expression Is Associated with Poorer Survival in Patients with Head and Neck Squamous Cell Carcinoma , 2011, Clinical Cancer Research.

[17]  Q. Hu,et al.  XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis , 2011, Prostate Cancer and Prostatic Diseases.

[18]  Ping Yang,et al.  Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis , 2011, Molecular Biology Reports.

[19]  Hong-qiang Guo,et al.  XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[20]  Jun Liang,et al.  Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[21]  Xi-Dai Long,et al.  Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1–related hepatocellular carcinoma in the Guangxi population , 2010, Hepatology.

[22]  P. Brandt-Rauf,et al.  XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study , 2010, Journal of carcinogenesis.

[23]  N. Rothman,et al.  DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. , 2010, Neuro-oncology.

[24]  Y. Chawla,et al.  Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population , 2009, Molecular and Cellular Biochemistry.

[25]  Robert E. Derr,et al.  Performing Exact Logistic Regression with the SAS System — Revised 2009 , 2009 .

[26]  Long-Bang Chen,et al.  XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. , 2008, World journal of gastroenterology.

[27]  R. Gérolami,et al.  DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. , 2007, European journal of cancer.

[28]  H. Bartsch,et al.  Genetic risk profiles for cancer susceptibility and therapy response. , 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[29]  N. Malats,et al.  Genetic variation in the base excision repair pathway and bladder cancer risk , 2007, Human Genetics.

[30]  Y. Nakanishi,et al.  Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. , 2006, Lung cancer.

[31]  J. Luketich,et al.  Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never‐smokers , 2006, Molecular carcinogenesis.

[32]  L. Koniaris,et al.  Molecular pathogenesis of hepatocellular carcinoma. , 2006, The Journal of surgical research.

[33]  Xi-Dai Long,et al.  The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[34]  Chien-Jen Chen,et al.  Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. , 2005, International journal of epidemiology.

[35]  J. Goedert,et al.  Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity , 2005, Cancer Epidemiology Biomarkers & Prevention.

[36]  O. Musso,et al.  Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma , 2005, FEBS letters.

[37]  I. Andrulis,et al.  Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  M. Seto,et al.  Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan. , 2004, Cancer genetics and cytogenetics.

[39]  P. Brennan,et al.  Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  J. G. Boer.  Polymorphisms in DNA repair and environmental interactions. , 2002 .

[41]  Jack A. Taylor,et al.  Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  E. Holly,et al.  A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. , 2002, Cancer research.

[43]  W. Tan,et al.  Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population , 2002, International journal of cancer.

[44]  A. Olshan,et al.  XRCC1 polymorphisms and head and neck cancer. , 2002, Cancer letters.

[45]  Jack A. Taylor,et al.  DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  B. Glickman,et al.  Identification of single nucleotide polymorphisms in human DNA repair genes , 2022 .

[47]  J. Hoeting,et al.  Statistics and Data Analysis , 1997 .

[48]  I. M. Jones,et al.  Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. , 1998, Cancer research.

[49]  J. Tainer,et al.  Base excision repair enzyme family portrait: integrating the structure and chemistry of an entire DNA repair pathway. , 1997, Structure.